Nuvilex: The Real Story
15 août 2013 15h20 HE
|
Nuvilex, Inc.
SAN DIEGO, CA--(Marketwired - Aug 15, 2013) - The OTC Journal, the longest running electronic newsletter focused on the small cap and microcap sectors, wishes to provide accurate information...
Stock Market Media Group Issues Nuvilex, Inc. Road to Phase III Clinical Trials Report
15 août 2013 08h30 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Aug 15, 2013) - Stock Market Media Group, a research and content development investor relations firm, issued its Third Quarter Update and the first installment of its...
Nuvilex, Inc. to Control 2 of the Big 3 Multi Billion Dollar Drug Markets With Technology
07 août 2013 08h30 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Aug 7, 2013) - Nuvilex, Inc. (OTCQB: NVLX) is methodically laying the foundation today for what should be a very busy and promising future tomorrow. After making a...
Nuvilex, Inc. Strengthens Its Hand in the Cancer Arena With Purchase of Assets
30 juil. 2013 08h30 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jul 30, 2013) - Nuvilex, Inc. (OTCQB: NVLX) became a much more valuable company in July when it closed a deal it was fully prepared to pay a great deal more money for,...
Nuvilex, Inc. Moves Closer to Head to Head With Eli Lilly in Phase III Clinical Trials
25 juil. 2013 08h30 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jul 25, 2013) - Nuvilex, Inc. (OTCQB: NVLX) is currently preparing the way to challenge Eli Lilly's blockbuster cancer drug, Gemzar, and doing so with the knowledge...
Nuvilex, Inc. Acquisition Could Be Steal of the Century and Worth Billions
18 juil. 2013 08h30 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jul 18, 2013) - In a recently announced acquisition deal, Nuvilex, Inc. (OTCQB: NVLX), pulled off what can only be described as the steal of the century. The company...
Nuvilex, Inc. Returns 100 Million Shares to Company's Treasury After Completing Acquisition
16 juil. 2013 09h30 HE
|
Nuvilex, Inc.
SILVER SPRING, MD--(Marketwired - Jul 16, 2013) - Nuvilex, Inc. (OTCQB: NVLX), (the "Company"), an international biotechnology company and provider of natural products and cell and gene therapy...
Nuvilex, Inc. Will Enter Phase III Trials With Advantages Using Cell Encapsulation
09 juil. 2013 08h30 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jul 9, 2013) - When Nuvilex, Inc. (OTCQB: NVLX) enters its pivotal Phase III clinical trial using its cell encapsulation technology combined with the anti-cancer drug...
Nuvilex, Inc., Johnson & Johnson, and Medtronic, Inc., All Developing Type of Artificial Pancreas for Diabetics
02 juil. 2013 08h30 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jul 2, 2013) - While Medtronic, Inc. and Johnson & Johnson are developing devices that can essentially act as a type of "artificial pancreas," Nuvilex, Inc.'s...
Nuvilex, Inc. a Biotech Developing Treatments for Healthcare's Hard Targets
26 juin 2013 08h30 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jun 26, 2013) - Nuvilex, Inc. (OTCQB: NVLX) executives aren't daunted by the statistics. As a matter of fact, they're aware the research they do is directed...